ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 230 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,958,274 | -36.3% | 2,377,665 | -21.5% | 12.23% | -10.9% |
| Q2 2023 | $20,334,212 | -24.0% | 3,030,434 | 0.0% | 13.72% | -22.4% |
| Q1 2023 | $26,758,732 | +15.6% | 3,030,434 | 0.0% | 17.69% | +13.8% |
| Q4 2022 | $23,152,516 | -9.7% | 3,030,434 | -15.8% | 15.55% | +50.3% |
| Q3 2022 | $25,635,000 | +1.5% | 3,600,434 | +15.4% | 10.35% | -24.5% |
| Q2 2022 | $25,244,000 | +149.1% | 3,120,434 | +1139.8% | 13.71% | +176.9% |
| Q1 2021 | $10,133,000 | -58.8% | 251,695 | -39.5% | 4.95% | -32.5% |
| Q4 2020 | $24,609,000 | – | 416,200 | – | 7.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
| BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
| Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
| Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
| Triatomic Management LP | 121,166 | $813,024 | 0.83% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
| Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
| Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
| ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
| Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |